Peter D. Montan

708 total citations
14 papers, 492 citations indexed

About

Peter D. Montan is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Peter D. Montan has authored 14 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cancer Research. Recurrent topics in Peter D. Montan's work include Lipoproteins and Cardiovascular Health (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Pharmaceutical Economics and Policy (3 papers). Peter D. Montan is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Pharmaceutical Economics and Policy (3 papers). Peter D. Montan collaborates with scholars based in United States, Greece and Austria. Peter D. Montan's co-authors include Eliscer Guzman, Constantine E. Kosmas, Andreas Sourlas, Delia Silverio, Mario J. García, Mario J. García, Gordon Mallarkey and Evdokia Sourla and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Translational Medicine and Patient Preference and Adherence.

In The Last Decade

Peter D. Montan

14 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter D. Montan United States	11	197	163	103	98	75	14	492
Andreas Sourlas Greece	12	240 1.2×	172 1.1×	102 1.0×	117 1.2×	69 0.9×	18	517
Fabiana Hanna Rached Brazil	10	243 1.2×	235 1.4×	150 1.5×	152 1.6×	77 1.0×	26	545
Elisenda Climent Spain	16	434 2.2×	182 1.1×	132 1.3×	154 1.6×	95 1.3×	59	790
Rafael Bitzur Israel	13	228 1.2×	244 1.5×	167 1.6×	87 0.9×	141 1.9×	30	712
P. Brizzi Italy	11	255 1.3×	225 1.4×	80 0.8×	143 1.5×	66 0.9×	17	732
Victoria Marco-Benedí Spain	14	312 1.6×	176 1.1×	68 0.7×	98 1.0×	26 0.3×	54	557
Paul J.W.H. Kappelle Netherlands	12	161 0.8×	158 1.0×	78 0.8×	65 0.7×	102 1.4×	15	393
A. Tselepis Greece	13	166 0.8×	132 0.8×	80 0.8×	100 1.0×	198 2.6×	23	539
Delia Silverio United States	9	123 0.6×	82 0.5×	81 0.8×	59 0.6×	40 0.5×	10	301
Oscar Jorba Jorba Spain	12	253 1.3×	204 1.3×	76 0.7×	78 0.8×	105 1.4×	17	516

Countries citing papers authored by Peter D. Montan

Since Specialization

Citations

This map shows the geographic impact of Peter D. Montan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Montan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Montan more than expected).

Fields of papers citing papers by Peter D. Montan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Montan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Montan. The network helps show where Peter D. Montan may publish in the future.

Co-authorship network of co-authors of Peter D. Montan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Montan. A scholar is included among the top collaborators of Peter D. Montan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Montan. Peter D. Montan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, et al.. (2019). Anti-inflammatory therapy for cardiovascular disease. Annals of Translational Medicine. 7(7). 147–147. 49 indexed citations

Montan, Peter D., et al.. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine. 7(16). 393–393. 40 indexed citations

Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, Peter D. Montan, & Eliscer Guzman. (2019). Dysfunctional high-density lipoprotein and atherogenesis. Vessel Plus. 2019. 6 indexed citations

Kosmas, Constantine E., Andreas Sourlas, Gordon Mallarkey, et al.. (2019). Therapeutic management of hyperlipoproteinemia (a). Drugs in Context. 8. 1–11. 15 indexed citations

Kosmas, Constantine E., et al.. (2018). Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia. Patient Preference and Adherence. Volume 12. 2263–2266. 25 indexed citations

Kosmas, Constantine E., et al.. (2018). Primary genetic disorders affecting high density lipoprotein (HDL). Drugs in Context. 7. 1–11. 11 indexed citations

Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, Peter D. Montan, & Eliscer Guzman. (2018). Role of spironolactone in the treatment of heart failure with preserved ejection fraction. Annals of Translational Medicine. 6(23). 461–461. 15 indexed citations

Kosmas, Constantine E., et al.. (2018). High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs in Context. 7. 1–9. 159 indexed citations

Kosmas, Constantine E., et al.. (2018). Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus. Drugs in Context. 7. 1–7. 17 indexed citations

10.

Kosmas, Constantine E., et al.. (2018). Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia. SHILAP Revista de lepidopterología. 6(3). 63–63. 74 indexed citations

11.

Kosmas, Constantine E., et al.. (2018). The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease. Clinical Medicine Insights Endocrinology and Diabetes. 11. 3075455297–3075455297. 49 indexed citations

12.

Kosmas, Constantine E., et al.. (2017). Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy. Drugs in Context. 6. 1–7. 23 indexed citations

13.

Kosmas, Constantine E., et al.. (2017). Effects of Statins on Cardiovascular Outcomes in Patients With Chronic Kidney Disease. 2017(9). 0–0. 4 indexed citations

14.

Kosmas, Constantine E., et al.. (2017). Effects of Statins on Cardiovascular Outcomes in Patients With Chronic Kidney Disease. 9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact